Sort
11,323 grants matching “glioblastoma”
Molecular basis for the impact of sex on brain tumorigenesis
$374,063Joshua B Rubin · Washington University · R01 · FY2021 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$374,063Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Screening for adjuvant gliobalstoma therapeutics
$374,063Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2017 · NS
Screening for adjuvant gliobalstoma therapeutics
$374,063Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2016 · NS
Damaged RNA as a mediator of alkylation responses
$374,063Nima Mosammaparast · Washington University · R01 · FY2021 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$374,063Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Intracellular Host Tumor Responses to oHSVs and Avenues to Overcome These
$373,931E. Antonio Chiocca · Ohio State University · P01 · FY2016 · CA
Elucidating the function of the widely inactivated phosphatase PTPRD in the molec
$373,812Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Damaged RNA as a mediator of alkylation responses
$373,766Nima Mosammaparast · Washington University · R01 · FY2020 · CA
Differential response of glioblastomas to microtubule targeting agents
$373,728Nephi Stella · University Of Washington · R01 · FY2020 · CA
AI-powered chemical proteomics for drug discovery targeting orphan proteins
$373,702Lei Xie · Hunter College · R01 · FY2024 · GM
Targeting Refractory EGFR-Driven Tumors By Induction Of Dominant-Negative EGFR Splicing Variants
$373,641Luca Cartegni · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA
LNP-BASED SNAS TO OVERCOME IMMUNOSUPPRESSION IN GLIOBLASTOMA
$373,470Flashpoint Therapeutics, Inc. · · FY2025 · Defense Health Agency
Extratumoral biological determinants that decrease survival in older adults with glioblastoma
$373,450Derek Alan Wainwright · Loyola University Chicago · R01 · FY2024 · NS
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$373,424Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · NS
Biochemistry of Brain Tumor Microvessel Development
$373,389John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2006 · NS
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$373,358Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2024 · NS
Collaborative Systems for Analyzing Tissue Microarrays
$373,339David J Foran · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2011 · CA
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
$373,300W Mark Saltzman · Yale University · R01 · FY2019 · CA
Bioreactor-based Manufacturing of Glioblastoma Organoids
$373,293Yonghyun Kim · University Of Alabama Tuscaloosa · · FY2020 · ENG
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$373,258Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2021 · NS
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
$373,187Jing Li · Wayne State University · R01 · FY2022 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$373,133John H Sampson · Duke University · R01 · FY2015 · NS
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$373,062Richard B Silverman · Northwestern University · R01 · FY2025 · CA
Mechanisms of adhesion and invasion in hyaluronic acid matrices
$372,990Sanjay Kumar · University Of California Berkeley · R01 · FY2021 · CA